Spansules Pharmatech Private Limited, a active private limited company, was established on 09 October 2000 in Hyderabad, Telangana, India. Engaging in drug formulation & development within the manufacturing sector, it holds CIN: U24230TG2000PTC035421. Registered under ROC Roc Hyderabad. it is unlisted. It has an authorized capital of ₹5.00 Cr and a paid-up capital of ₹5.00 Cr.
It upholds a compliant status. Employing 52 professional, Its leadership includes Rama Devi Guttikonda (Director), Haswanth Rao Guttikonda (Director), Harika Rao Guttikonda (Director). It holds ₹55.24 Cr open charges and ₹8.00 Cr settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at Plot No.59, G-3,Sri Venkateswara Towers Bhagyanagar Colony, Hyderabad, Telangana, 500072.
U24230TG2000PTC035421
035421
09 October 2000
₹5.00 Cr
₹5.00 Cr
Roc Hyderabad
Unlisted
Active
Explore comprehensive insights into Spansules Pharmatech Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Rama Devi Guttikonda | Director | 09 Oct 2000 | Current |
| Haswanth Rao Guttikonda | Director | 07 Feb 2020 | Current |
| Harika Rao Guttikonda | Director | 07 Feb 2020 | Current |
| Venkata Subba Rao Guttikonda | Managing Director | 09 Oct 2000 | Current |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Spansules Pharmatech Private Limited, for the financial year ended 2023, experienced modest growth in revenue, with a 1.84% increase. The company also saw a substantial improvement in profitability, with a 14.85% increase in profit. The company's net worth Soared by an impressive increase of 15.67%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2024, Spansules Pharmatech had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹552,400,000.00
₹80,000,000.00
| Date | Lender | Amount | Status |
|---|---|---|---|
| 10 May 2022 | Hdfc Bank Limited | ₹2.00 M | Open |
| 08 Feb 2022 | Hdfc Bank Limited | ₹24.77 Cr | Open |
| 27 May 2015 | Canara Bank | ₹0.80 M | Open |
| 21 Oct 2010 | Canara Bank | ₹0.30 M | Open |
| 14 Dec 2002 | Canara Bank | ₹0.30 M | Open |
Explore comprehensive loan charge details -
Spansules Pharmatech has a workforce of 52 employees as of Sep 25, 2025. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Spansules Pharmatech, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Spansules Pharmatech's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Progress on Spansules Pharmatech Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was documented.
Progress on Spansules Pharmatech Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Hyderabad. was documented.
A charge with Canara Bank of Rs. 30.13 Cr registered on 13 Jun 2002 with Charge ID 90128215 was modified on 21 Jan 2023. was recorded as a recent event.
Progress on A charge with Hdfc Bank Limited of Rs. 24.77 Cr registered on 08 Feb 2022 with Charge ID 100540796 was modified on 07 Jun 2022. was documented.
Progress on A charge with Hdfc Bank Limited amounted to Rs. 0.20 Cr with Charge ID 100586682 was registered on 10 May 2022. was documented.
A charge registered on 23 Sep 2021 via Charge ID 100483729 with Others was fully satisfied on 29 Mar 2022. was recorded as a recent event.
The CIN of Spansules Pharmatech Private Limited is U24230TG2000PTC035421.
Spansules Pharmatech Private Limited is headquartered at Plot No.59, G-3,Sri Venkateswara Towers Bhagyanagar Colony, Hyderabad, Telangana, 500072.
Spansules Pharmatech Private Limited was incorporated on 09 October 2000.
The current directors of Spansules Pharmatech Private Limited are
The primary industry of Spansules Pharmatech Private Limited is Manufacturing.
Spansules Pharmatech Private Limited is unlisted.
The authorized capital of Spansules Pharmatech Private Limited is ₹5.00 Cr, and the paid-up capital is ₹5.00 Cr.
The compliance status of Spansules Pharmatech Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX